Innovating Works

OZB

Desconocido
SINPAIN: A game changer for the treatment of osteoarthritis: a cost effective combined advanced therapy to tr... OZ BIOSCIENCES SAS participó en un HORIZON EUROPE: HORIZON-HLTH-2021-TOOL-06 According to the WHO Osteoarthritis (OA) is one major course of years lived with disability in the elderly and considered a high burden dise...
2022-05-19 - 2026-10-31 | Financiado
cmRNAbone: 3D Printed Matrix Assisted Chemically Modified RNAs Bone Regenerative Therapy for Trauma and Osteopo... OZ BIOSCIENCES SAS participó en un H2020: H2020-SC1-BHC-2018-2020 Due to life style changes and ageing of our industrialized nations, bone traumatic injuries and osteoporosis induced fragile fracture are an...
2019-11-24 - 2024-06-30 | Financiado
SBR: SMART BONE REGENERATION OZ BIOSCIENCES SAS participó en un H2020: H2020-SC1-BHC-2018-2020 The management and reconstruction of bone defects is a significant global healthcare challenge. While autografts offer ideal compatibility,...
2019-11-24 - 2024-12-31 | Financiado
OcuTher: Educational Network in Ocular Drug Delivery and Therapeutics OZ BIOSCIENCES SAS participó en un H2020: H2020-MSCA-ITN-2016 Ocular drug development has transformed from niche area to a major field in drug development in which many companies, including European big...
2016-08-16 - 2020-10-31 | Financiado
NANOMED: Nanomedicine an integrative approach OZ BIOSCIENCES SAS participó en un H2020: H2020-MSCA-ITN-2015 Nanomedicine (NM) is regarded as one of the most promising applications of nanotechnology, as it would allow the development of tailored the...
2015-08-11 - 2019-12-31 | Financiado
GAMBA: Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis OZ BIOSCIENCES SAS participó en un FP7: This consortium develops a novel gene-activated matrix platform for bone and cartilage repair with a focus on osteoarthritis-related tissue...
Financiado
UniVax: A Universal Influenza Vaccine through Synthetic Dendritic Cell Targeted Self Replicating RNA Vac... OZ BIOSCIENCES SAS participó en un FP7: Although vaccination is the cornerstone of prophylaxis, current vaccines provide only moderate protection. Most employ inactivated or protei...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.